By
AmyT on
January 24, 2011
I can’t help it. This reminds me of the movie City Slickers, in which one of the characters has messed up his life, and his friends tell him he’s getting a “do-over.” The young company Dance Pharmaceuticals, based in downtown San Francisco, is basically on a mission to salvage the good parts of Pfizer’s failed inhaled insulin Exubera (not the awkward delivery device!) and launch a second coming of the base product that is “simpler,…
Read more »
In November, we hosted a logo design contest for famous diabetes educator Gary Scheiner’s newest venture, Type 1 University, a series of online diabetes education courses. The winner was the talented D-OC leader Gina Capone. The grand prize for Gina was a lifetime of diabetes education classes, and Gary was also kind enough to invite bloggers to attend one of his classes for free as a trial session.
Type 1 University provides eight different classes,…
Read more »
Have we mentioned that we are hard core fans of Blünt Lancet? Nope, not those overused needles that haven’t been changed since daylight savings time ended. I’m talking about the awesome D-rock band that made the girls swoon back in the early ’90s!
Haven’t heard of them? Don’t worry, it’s not that you weren’t hip, even if you were old enough to remember their “heyday.” Is Blünt Lancet really a “blink-and-you’ll miss-them” has-been group making…
Read more »
The new contact form we launched here recently to make it easier for people to share their thoughts and contribute ideas is bringing in some very interesting stuff. One note that caught our attention was a query from a woman named Sarah:
“I was diagnosed with type 2 diabetes in 2001. I currently am well-controlled on oral medication, but I am also fat (not, I’m sure you will agree, an unusual situation). When my endo says…
Read more »
Last week not one, not two, but three websites were launched by Big Pharma to help educate people with diabetes. Actually, there were four Pharma companies at work here: NovoNordisk launched info warehouse Cornerstones4Care; Sanofi-Aventis started a new customer-facing blog, Discuss Diabetes; and Bristol Myer Squibb and AstraZeneca teamed up for something called The Type 2 Talk, an attempt at improving the conversation between T2 patients and their healthcare providers.
A lot of money, time,…
Read more »
